TIFFANY BYRD: Open Payments
NPI 1114287299 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,521 in 100 payments from 12 companies in 2025. Trend: 2023 $1,325 · 2024 $1,694 · 2025 $1,521
Food & beverage: $1,521
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $345 |
| Janssen Biotech, Inc. | 22 | $311 |
| Regeneron Healthcare Solutions, Inc. | 15 | $265 |
| UCB, Inc. | 9 | $174 |
| Novartis Pharmaceuticals Corporation | 14 | $154 |
| PFIZER INC. | 5 | $104 |
| Galderma Laboratories, L.P. | 2 | $45 |
| Botanix SB Inc | 2 | $44 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| LEO Pharma Inc. | 1 | $20 |
Products named: TREMFYA, DUPIXENT, RINVOQ, Bimzelx, SKYRIZI, CIBINQO, COSENTYX, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
